The microenvironment in spheroids mimics the in vivo physiology. Therefore, spheroids represent a valuable tool for research on the development and homeostasis of organs and tissues and provide crucial insights into the formation and structural composition of tumors.
- Sirenko O, et al. High-Content Assays for Characterizing the Viability and Morphology of 3D Cancer Spheroid Cultures
Assay Drug Dev Technol 13/7:402-414, 2015.
Researchers use 96- or 384-well Ultra-Low Attachment surface-coated spheroid microplates for the generation of 3D spheroids from three different human tumor cell lines. They were able to demonstrate that these spheroids could be analyzed with high content imaging using low and high magnifications. The relevance of the model was confirmed by testing 119 known approved anticancer drugs on one of the cell lines.
- Comley J. Spheroids Rapidly Becoming a Preferred 3D Culture Format
Drug Discovery World Spring 2017:31-49, 2017.
In this article, several current approaches for 3D spheroid cultures, including Corning spheroid microplates, are reviewed and discussed.
- Molla A, et al. Unsuccessful Mitosis in Multicellular Tumor Spheroids
Oncotarget 25/8:28769-28784, 2017.
Binucleated cells, originating from unsuccessful mitosis, are frequently observed in human tumors. The authors of this article demonstrate that certain human tumor cells, cultured as spheroids in 3D, also exhibit unsuccessful mitosis. These multicellular tumor spheroids however, still remain sensitive to certain mitotic drugs. In conclusion, multicellular tumor spheroids therefore can be used as a relevant model for drug testing.
- Senkowski W. High-throughput Screening Using Multicellular Tumor Spheroids to Reveal and Exploit Tumor-specific Vulnerabilities
Doctoral Thesis, Uppsala: Acta Universitatis Upsaliensis, p.50, 2017.
Senkowski describes in his online-published Ph.D. thesis the use of multicellular tumor spheroids, containing both proliferating and quiescent cells, for more consistent drug testing and screening, when compared to conventional two-dimensional tissue culture models. In particular, it is demonstrated in this work that previously unknown tumor-specific vulnerabilities can be detected using the more in vivo-like 3D model.
- Kota S, et al. A Novel Three-Dimensional High-throughput Screening Approach Identifies Inducers of a Mutant KRAS Selective Lethal Phenotype
Oncogene, 2018.
The authors demonstrate the necessity of evaluating potential drugs in the 3D cell environment. Spheroids were generated of isogenic cell lines, in which genes of the RAS proteins were mutated. RAS proteins play an important role in the extracellular-intracellular signaling pathways and are found to be commonly mutated in cancer. Spheroids were subjected to Proscillaridin A, which was identified as selective inhibitor of cells in which the RAS protein KRAS was mutated. The discovery of Proscillaridin A would have been missed out if the efficacy would have been tested in standard 2D culturing methods.
- Madoux F, et al. A 1536-well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids
SLAS Discovery: Advancing Life Sciences R & D, 22, 516-524, 2017.
In this work the authors from the SCRIPPS Institute investigate the cytotoxic effects of about 3.300 drug compounds in a 3D assay using spheroids which were generated in a 1536-well microplate custom designed by Corning. The plate features an Ultra-Low Attachment surface which allowed for the parallel formation, measurement of size as well as viability testing of the spheroids in a robust and reproducible manner.